Gå direkt till huvudinnehållet

P/S-Prokalcitonin (P/S-ProCT)

Senast reviderad:

  1. Tvede M. Procalcitonin - akut inflammatorisk markør ved infektioner. Ugeskr Læger 2004; 166: 3795. PubMed  
  2. Ternhag A, Cars O, Norman C, Struwe J. Antibiotika eller inte – prokalcitonin kan vägleda behandlingsval. Läkartidningen 2010 Apr 14-20;107(15):985-8. PMID: 20464915. PubMed  
  3. Bouadma L, Luyt C-E, Tubach F, et al. Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial. Lancet 2010; 375: 463-74. PubMed  
  4. Carrol ED, Thomson AP, Hart CA. Procalcitonin as a marker of sepsis. Int J Antimicrob Agents 2002; 20: 1-9. PubMed  
  5. Christ-Crain M, Stolz D, Bingisser R, et al. Procalcitonin Guidance of Antibiotic Therapy in Community-acquired Pneumonia: A Randomized Trial. Am J Respir Crit Care Med 2006; 174: 84-93. PubMed  
  6. Manzano S, Bailey B, Girodias JB, Galetto-Lacour A, Cousineau J, Delvin E. Impact of procalcitonin on the management of children aged 1 to 36 months presenting with fever without source: a randomized controlled trial. Am J Emerg Med 2010; 28: 647-53. American Journal of Emergency Medicine  
  7. Uzzan B, Cohen R, Nicolas P, Cucherat M, Perret GY. Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: a systematic review and meta-analysis. Crit Care Med 2006; 34: 1996-2003. PubMed  
  8. Ternhag A.Procalcitonin vid akuta infektioner - Kan det minska onödig antibiotikaförskrivning? STRAMA 2009. www.strama.org  
  9. Briel M, Schuetz P, Mueller B et al. Procalcitonin-guided antibiotic use vs standard approach for acute respiratiry tract infections in primary care. Arch Intern Med 2008; 168: 2000-7. PubMed  
  10. Schrøder H, Lodahl D. Procalcitonin som markør for svære bakterielle infektioner hos børn. Ugeskr Læger 2004; 166: 3804-7. PubMed  
  11. Blommendahl J, Janas M, Laine S et al. Comparison of procalcitonin with CRP and differential white blood cell count for diagnosis of culture-proven neonatal sepsis. Scand J Infect Dis 2002; 34: 620-2. PubMed  
  12. Chiesa C, Pellegrini G, Panero A et al. C-reactive protein, interleukin-6, and procalcitonin in the immediate postnatal period: influence of illness severity, risk status, antenatal and perinatal complications, and infection. Clin Chem 2003; 49: 60-8. PubMed  
  13. Carrol ED, Newland P, Riordan FA et al. Procalcitonin as a diagnostic marker of meningococcal disease in children presenting with fever and a rash. Arch Dis Child 2002; 86: 282-5. PubMed  
  14. Schuetz P, Wirz Y, Sager R. et al. Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections. Cochrane Database Syst Rev. 2017 Oct 13;10:CD007498. PMID: 29025194 PubMed  
  • Anders Kallner, docent och fd överläkare, Karolinska universitetslaboratoriet, Karolinska universitetssjukhuset

Tidigare sakkunniga

  • Geir Thue, specialist i allmänmedicin och professor vid NOKLUS/Seksjon for allmennmedisin, Universitetet i Bergen
  • Sverre Sandberg, professor, föreståndare för NOKLUS och avdelningsledare vid Laboratorium for klinisk biokjemi, Haukeland Universitetssykehus, Norge